My deep interest for science led me to pursue a Biochemistry degree at the University of Porto, blending mechanistic insight of chemistry with its complex application to living systems. My research journey began in 2014 at ICBAS, where I evaluated a Group B Streptococcus vaccine's pre-clinical efficacy in elderly and diabetic mice. In 2016, I joined Margarida Saraiva’s lab at i3S, exploring how Mycobacterium tuberculosis clinical isolates impact inflammasome activation, influencing tuberculosis severity. Between 2018-2024 I developed my PhD project in Immunology as part of the FCT-funded PhD program Biology at the Host-Microbe Interface, which joined the forces of 3 leading research institutes in Lisbon: Instituto de Medicina Molecular (iMM), Instituto Gulbenkian de Ciência (IGC) and Instituto de Tecnologia Química e Biológica (ITQB). My work revealed the pivotal role of regulatory T cells in tissue-resident memory T cell generation during diverse immune responses. Additionally, I completed a clinical trials course, bridging research with therapeutic applications. In March of 2024, I graduated from the Faculty of Medicine of University of Lisbon, obtaining my PhD degree with distinction and honours. From September 2022 to the present I have been working as a junior post-doctoral fellow under the supervision of Prof. Bruno Silva-Santos at iMM (now Gulbenkian Institute for Molecular Medicine, GIMM), where I have been studying the protective role of Delta One T (DOT) cells in cancer in the context of an FCT-funded project and a new two-year grant from Liga Portuguesa Contra o Cancro. Throughout these years doing research, I have been able to combine the worlds of fundamental biology and clinical application, actively contributing for the development of immunology knowledge and tools applied to infection and cancer, towards providing new ways to improve health and life quality.